MFF
JAZZ icon

Michels Family Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Michels Family Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$299K Sell
1,583
-120
-7% -$21K 0.22% 109
2025
Q4 		$290K Sell
1,703
-25
-1% -$3.83K 0.21% 113
2025
Q3 		$228K Buy
+1,728
New +$207K 0.18% 127

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Michels Family Financial's JAZZ Position: Q1 2026 in Review

Michels Family Financial reduced its Jazz Pharmaceuticals (JAZZ) stake by 7% in Q1 2026, selling an estimated $21K and leaving 1,583 shares worth $299K. The position accounts for 0.22% of the portfolio, ranked #109.

Michels Family Financial first reported a position in JAZZ in Q3 2025 and has held it in 3 quarters since. 573 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Michels Family Financial held 1,583 shares of Jazz Pharmaceuticals worth $299K as of Q1 2026.
  • Michels Family Financial sold 120 Jazz Pharmaceuticals shares in Q1 2026, an estimated $21K.
  • Jazz Pharmaceuticals made up 0.22% of Michels Family Financial's portfolio in Q1 2026, its #109 holding.
  • Michels Family Financial first reported a position in Jazz Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Michels Family Financial's 13F filing for Q1 2026, filed 24 Apr 2026.